SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

PIRAMAL PHARMA

BSE: 543635 29 Jul 2025
Healthcare
₹ 216.35
PIRAMAL PHARMA LIMITED specializes in Pharmaceuticals within the Healthcare sector.

PIRAMAL PHARMA - Share Price & Details

Market Cap
₹27,331
High /Low
308.0 / 165.0
Stock P/E
317.0
Book Value
₹61.3
Dividend Yield
0.07
ROCE
6.45
ROE
₹1.11
Face Value
10.0
PEG Ratio
-8.2
EVEBITDA
₹19.9
Debt
4,856
CMP / FCF
1,240
Debt to equity
₹0.6
NP Ann
91.1
High price all time
308.0
Piotroski score
₹7.0
Graham Number
32.0
No. Eq. Shares
133.0
Net CF
₹-36.9
Net profit
98.1
Price to book value
3.35
Interest Coverage
₹1.9
Low price all time
61.6
Industry PE
34.0
Reserves
₹6,801
Free Cash Flow
₹233

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.4691.0
Triochem Products Ltd.,3.25-4.52NA-18.440
PIRAMAL PHARMA LIMITED11508.01131.49698.80.8527,331317.0
Dr. Lal Pathlabs Limited6,024.001,484.005,772.0017.782533051.8
Eris Lifesciences Limited4,215.20304.704,047.702.232446069.8

Peer Comparison Chart


About PIRAMAL PHARMA

PIRAMAL PHARMA LIMITED, with Security Code 543635, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Would You Accumulate or Wait on Piramal Pharma Limited (PPLPHARMA) - Breakthrough profit margins

(23 Jul 2025)
【Market Focus】✌️ Our platform specializes in identifying explosive growth stocks with a proven record of exceeding 200% ROI for savvy...
Read more →

Piramal Pharma Limited (PPLPHARMA) Expands into New Market - Market-beating returns

(23 Jul 2025)
Piramal Pharma Limited (PPLPHARMA) Expands into New Market ✌️【Investor Trends】✌️ Every stock we recommend is backed by data, charts,...
Read more →

Piramal Pharma Limited (PPLPHARMA) Quarterly Results Are Out - Unbelievable profit margins

(23 Jul 2025)
Piramal Pharma Limited (PPLPHARMA) Quarterly Results Are Out ✌️【Market Insights】✌️ Receive timely alerts on market catalysts and sector...
Read more →

Piramal Pharma Faces Decline Amid Broader Market Gains and Mixed Performance Indicators

(23 Jul 2025)
Piramal Pharma's stock has declined today, underperforming its sector. It reached an intraday low and shows mixed performance against...
Read more →

Piramal Pharma receives upgrade in LT credit ratings

(22 Jul 2025)
From CARE. Piramal Pharma announced that CARE has revised the credit ratings assigned to the company as under:.
Read more →

Piramal Pharma Limited (PPLPHARMA) Hits 52 Week High - Free Capital Allocation Plans

(21 Jul 2025)
Piramal Pharma Limited (PPLPHARMA) Hits 52 Week High ✌️【Investor Updates】✌️ Real-time predictions and expert analysis of stock trends to...
Read more →

Company Updates